Sanmina Corp. Hits New 52-Week High of $196.00, Up 183.51%

Sanmina Corp. has reached a significant milestone by hitting a new 52-week high of USD 196.00 on April 27, 2026. This achievement underscores the company's strong performance in the Pharmaceuticals & Biotechnology sector, where it has demonstrated a remarkable one-year performance of 183.51%, significantly outpacing the S&P 500's 29.84% return. With a market capitalization of USD 12,249 million, Sanmina Corp. is classified as a small-cap company. The stock's price-to-earnings (P/E) ratio stands at 39.00, reflecting investor sentiment and market valuation. Additionally, the company maintains a debt-to-equity ratio of 0.31, indicating a relatively low level of debt compared to equity, which can be a positive sign for financial stability. Sanmina's return on equity is reported at 12.64%, showcasing its efficiency in generating profits from shareholders' equity. The price-to-book ratio is noted at 4.95, further illustrating the company's valuation in relation to its assets. Overall, Sanmina Corp.'s recent performance highlights its strong position within the industry.